BACKGROUND: Heart failure (HF) is a chronic disease of great clinical and economic significance for both the healthcare system and patients themselves. AIM: To determine the consumption of medical resources for treatment and care of HF patients and to estimate the related costs. METHODS: The study involved 400 primary care practices and 396 specialist outpatient clinics, as well as 259 hospitals at all reference levels. The sample was representative and supplemented with patient interview data. Based on the consumption of particular resources and the unit costs of services in 2011, costs of care for HF patients in Poland were estimated. Separate analyses were conducted depending on the stage of the disease (according to NYHA classification I-IV). The public payer's perspective and a one year time horizon were adopted. RESULTS: Direct annual costs of an HF patient's treatment in Poland may range between PLN 3,373.23 and 7,739.49 (2011), the main cost item being hospitalisation. The total costs for the healthcare system could be as high as PLN 1,703 million, which is 3.16% of the National Health Fund's budget (Ex. rate from 05.03.2012: 1 EUR = 4.14 PLN). CONCLUSIONS: The costs of treating heart failure in Poland are high; proper allocation of resources to diagnostic procedures and treatment may contribute to rationalisation of the relevant expenditure.
RCT Entities:
BACKGROUND:Heart failure (HF) is a chronic disease of great clinical and economic significance for both the healthcare system and patients themselves. AIM: To determine the consumption of medical resources for treatment and care of HF patients and to estimate the related costs. METHODS: The study involved 400 primary care practices and 396 specialist outpatient clinics, as well as 259 hospitals at all reference levels. The sample was representative and supplemented with patient interview data. Based on the consumption of particular resources and the unit costs of services in 2011, costs of care for HF patients in Poland were estimated. Separate analyses were conducted depending on the stage of the disease (according to NYHA classification I-IV). The public payer's perspective and a one year time horizon were adopted. RESULTS: Direct annual costs of an HF patient's treatment in Poland may range between PLN 3,373.23 and 7,739.49 (2011), the main cost item being hospitalisation. The total costs for the healthcare system could be as high as PLN 1,703 million, which is 3.16% of the National Health Fund's budget (Ex. rate from 05.03.2012: 1 EUR = 4.14 PLN). CONCLUSIONS: The costs of treating heart failure in Poland are high; proper allocation of resources to diagnostic procedures and treatment may contribute to rationalisation of the relevant expenditure.
Authors: Aneta Mela; Elżbieta Rdzanek; Łukasz A Poniatowski; Janusz Jaroszyński; Marzena Furtak-Niczyporuk; Małgorzata Gałązka-Sobotka; Dominik Olejniczak; Maciej Niewada; Anna Staniszewska Journal: Front Pharmacol Date: 2020-09-08 Impact factor: 5.810
Authors: Okechukwu S Ogah; Simon Stewart; Obinna E Onwujekwe; Ayodele O Falase; Saheed O Adebayo; Taiwo Olunuga; Karen Sliwa Journal: PLoS One Date: 2014-11-21 Impact factor: 3.240
Authors: Michal M Farkowski; Mariusz Pytkowski; Aleksander Maciag; Dominik Golicki; Ilona Kowalik; Marcin Czech; Piotr Rucinski; Hanna Szwed Journal: J Interv Card Electrophysiol Date: 2016-08-03 Impact factor: 1.900